ARKG is trading at $49.80, with a +3.15% gain amid a broad healthcare rally; no specific fund catalyst is confirmed.
- The NYSE Healthcare Index was up 2.3% Thursday afternoon, alongside broad gains in healthcare ETFs and stocks.
- The move fits an afternoon recovery and rotation toward less rate-sensitive sectors after inflation-driven volatility.
- Tempus AI and CRISPR Therapeutics were higher, while other major ARKG holdings were mixed.